LF

Lawrence Friedhoff

DE Demerx: 5 patents #4 of 9Top 45%
AG Axovant Sciences Gmbh: 3 patents #1 of 13Top 8%
EI Eisai: 2 patents #451 of 998Top 50%
ES E.R. Squibb & Sons.: 2 patents #179 of 513Top 35%
MS Mitotech S.A.: 2 patents #6 of 29Top 25%
Overall (All Time): #343,550 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11304932 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease Shankar RAMASWAMY, Yandong Wen 2022-04-19
10034859 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease Shankar RAMASWAMY, Yandong Wen 2018-07-31
10022355 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder Shankar RAMASWAMY, Yandong Wen 2018-07-17
9744174 Method for noribogaine treatment in patients on methadone 2017-08-29
9591978 Methods and compositions for pre-screening patients for treatment with noribogaine 2017-03-14
9572890 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use Maxim V. Skulachev, Vladimir P. Skulachev, Audrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin +4 more 2017-02-21
9561233 Use of ibogaine for the treatment of pain 2017-02-07
9561232 Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use Emeline Maillet 2017-02-07
9345711 Methods for acute and long-term treatment of drug addiction 2016-05-24
9192676 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use Maxim V. Skulachev, Vladimir P. Skulachev, Andrey Aleksandrovich ZAMYATNIN, Eugeny S. Efremov, Vadim N. Tashlitsky +5 more 2015-11-24
7105540 Cholinesterase inhibitors to treat disorders of attention Paul Tiseo, Sharon L. Rogers 2006-09-12
6455544 Use of cholinesterase inhibitors to treat disorders of attention Paul Tiseo, Sharon L. Rogers 2002-09-24
5066480 Method of preventing or reducing adverse reactions to protamine using a thromboxane A.sub.2 receptor antagonist Martin L. Ogletree, William A. Schumacher, Gary J. Grover 1991-11-19
4925873 Method of treating skin injuries using thromboxane A.sub.2 receptor antagonists Laura L. Bolton 1990-05-15